What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
.
. Mt Sinai J Med. 2002 May;69(3):148-55. Mt Sinai J Med. 2002. PMID: 12035074 Review.
.
Item in Clipboard
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
